Cardinal Health, Inc. – Consensus Indicates Potential -1.5% Downside

DirectorsTalk Interviews

Cardinal Health, Inc. with ticker code (CAH) have now 13 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The range between the high target price and low target price is between 80 and 56 and has a mean target at 69.54. With the stocks previous close at 70.63 this would indicate that there is a downside of -1.5%. The day 50 moving average is 62.01 while the 200 day moving average is 56.08. The market cap for the company is $19,046m. Visit the company website at: https://www.cardinalhealth.com

The potential market cap would be $18,752m based on the market concensus.

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Share on:
Find more news, interviews, share price & company profile here for:

    Boku partners with Canva to boost access in Asia and Europe via localised payments

    Boku has announced a strategic partnership with Canva to expand the design platform’s reach across Asia and Europe through localised payment methods. The collaboration has already launched Vietnam’s MoMo digital wallet on Canva, with more integrations planned for 2025, aiming to make the platform more accessible in regions where card usage is low.

    Jubilee Metals to sell SA chrome and PGM assets for US$90m

    Jubilee Metals has issued a circular outlining plans to sell its Chrome and PGM Operations in South Africa to One Chrome (Pty) Ltd for up to US$90 million.

    Real Estate Credit Investments posts 2025 AGM circular

    Real Estate Credit Investments has issued its 2025 AGM circular and proxy form to shareholders. The meeting will take place on 17 September 2025 at East Wing, Trafalgar Court, St. Peter Port, Guernsey, with documents available via the National Storage Mechanism.

    Nuformix applies for US Orphan Drug Designation for NXP002 in IPF

    Nuformix has submitted an application to the US FDA for Orphan Drug Designation for tranilast, the active ingredient in its NXP002 inhaled therapy for idiopathic pulmonary fibrosis.

    Dekel Agri-Vision sees record cashew output, higher palm oil prices

    Dekel Agri-Vision has announced a July 2025 update, highlighting record monthly raw cashew nut processing of 533 tonnes at its Tiebissou plant, up 423% from July 2024.

    Diversified Energy delivers strong H1 2025 with Carlyle partnership boost

    Diversified Energy Company posted first-half 2025 results in line with expectations, delivering strong production growth, improved financial metrics, and $152 million in adjusted free cash flow

      Search

      Search